Nucleoside analogs as antiparasitic agents.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000962:Antimalarials / Q000494:pharmacology; D001200:Ascaris / Q000187:drug effects; D002590:Cestode Infections / Q000188:drug therapy; D003839:Deoxyadenosines / Q000627:therapeutic use; D006801:Humans; D051379:Mice; D009534:Niclosamide / Q000627:therapeutic use; D009705:Nucleosides / Q000627:therapeutic use*; D010272:Parasitic Diseases / Q000188:drug therapy*; D010879:Piperazines / Q000494:pharmacology; D010961:Plasmodium / Q000187:drug effects / Q000201:enzymology; D011528:Protozoan Infections / Q000188:drug therapy; D011691:Puromycin / Q000627:therapeutic use; D012552:Schistosomiasis / Q000188:drug therapy; D013762:Tetrahydrofolate Dehydrogenase / Q000378:metabolism; D014372:Tubercidin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000962:Antimalarials; D003839:Deoxyadenosines; D009705:Nucleosides; D010879:Piperazines; D011691:Puromycin; D009534:Niclosamide; D013762:Tetrahydrofolate Dehydrogenase; D014372:Tubercidin